Procter & Gamble Company (The) $PG Stock: Americana Partners LLC Increases Stake

Americana Partners LLC lifted its position in shares of Procter & Gamble Company (The) (NYSE:PG) by 4.5% during the 3rd quarter, Holdings Channel.com reports. The firm owned 80,071 shares of the company’s stock after purchasing an additional 3,412 shares during the quarter. Americana Partners LLC’s holdings in Procter & Gamble were worth $11,633,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. Ellis Investment Partners LLC lifted its position in Procter & Gamble by 0.7% in the third quarter. Ellis Investment Partners LLC now owns 8,816 shares of the company’s stock worth $1,281,000 after purchasing an additional 64 shares during the period. Clark Wealth Partners boosted its stake in Procter & Gamble by 20.6% during the third quarter. Clark Wealth Partners now owns 387 shares of the company’s stock worth $56,000 after buying an additional 66 shares in the last quarter. Whelan Financial increased its holdings in Procter & Gamble by 1.9% in the 3rd quarter. Whelan Financial now owns 3,689 shares of the company’s stock valued at $536,000 after buying an additional 68 shares during the period. KLCM Advisors Inc. increased its holdings in Procter & Gamble by 0.9% in the 1st quarter. KLCM Advisors Inc. now owns 7,890 shares of the company’s stock valued at $1,140,000 after buying an additional 70 shares during the period. Finally, Midwest Professional Planners LTD. raised its stake in shares of Procter & Gamble by 2.6% in the 2nd quarter. Midwest Professional Planners LTD. now owns 2,799 shares of the company’s stock valued at $410,000 after buying an additional 70 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors.

Procter & Gamble Stock Up 0.5%

NYSE PG opened at $161.42 on Friday. The stock’s 50 day simple moving average is $149.99 and its 200 day simple moving average is $148.94. Procter & Gamble Company has a one year low of $137.62 and a one year high of $167.25. The firm has a market cap of $374.14 billion, a PE ratio of 24.31, a price-to-earnings-growth ratio of 3.95 and a beta of 0.39. The company has a debt-to-equity ratio of 0.40, a current ratio of 0.72 and a quick ratio of 0.53.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Thursday, October 22nd. The company reported $2.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.89 by $0.11. The firm had revenue of $23.28 billion during the quarter, compared to the consensus estimate of $22.80 billion. Procter & Gamble had a return on equity of 31.02% and a net margin of 18.23%. The business’s revenue for the quarter was up 4.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.99 EPS. As a group, sell-side analysts forecast that Procter & Gamble Company will post 6.99 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Friday, October 23rd will be paid a $1.0885 dividend. The ex-dividend date is Friday, October 23rd. This represents a $4.35 dividend on an annualized basis and a dividend yield of 2.7%. Procter & Gamble’s dividend payout ratio (DPR) is 65.51%.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on PG. DZ Bank downgraded shares of Procter & Gamble from a “strong-buy” rating to a “hold” rating in a report on Tuesday. UBS Group set a $166.00 target price on shares of Procter & Gamble in a research note on Friday, October 23rd. Wells Fargo & Company increased their price target on shares of Procter & Gamble from $164.00 to $180.00 and gave the stock an “overweight” rating in a research report on Friday, October 23rd. Morgan Stanley increased their price target on shares of Procter & Gamble from $166.00 to $185.00 and gave the stock an “overweight” rating in a research report on Friday, October 23rd. Finally, Citigroup raised their price target on shares of Procter & Gamble from $180.00 to $187.00 and gave the stock a “buy” rating in a research note on Friday, October 23rd. Fifteen equities research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $170.57.

Procter & Gamble News Summary

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Analyst upgrade: Freedom Broker upgraded PG from “hold” to “buy,” providing a positive signal for the stock and reflecting greater confidence in the company’s outlook. Freedom Broker upgrades Procter & Gamble to buy from hold
• Positive Sentiment: Dividend appeal remains strong: Articles highlighted PG as a long-standing dividend leader, supporting its appeal to income-focused and defensive investors. The company’s record of dividend increases may help underpin demand for the shares, particularly when investors favor stable consumer-staples businesses. Dividend Kings article Trusted dividend stocks article
• Neutral Sentiment: Bond issuance adds balance-sheet context: PG’s euro- and dollar-denominated bond sale provides liquidity and funding flexibility, but it also draws attention to leverage, interest costs, and the company’s relatively elevated valuation. Procter & Gamble bond sale
• Neutral Sentiment: Growth story under review: Commentary on PG points to accelerating revenue growth, while also noting that higher operating costs could pressure margins and earnings. Investors are weighing improved sales momentum against cost inflation. Procter & Gamble revenue growth and costs What changed in Procter & Gamble’s story
• Negative Sentiment: Mixed rating signals and valuation risk: DZ Bank downgraded PG from “strong-buy” to “hold.” With shares trading at a premium valuation, a more cautious analyst stance could weigh on upside unless earnings growth accelerates. DZ Bank rating change
• Negative Sentiment: Advertising challenge produced only a limited win: Following PG’s challenge, the National Advertising Division supported Carpe’s $19.95 reference price but recommended changes or removal of other savings, free-shipping, comparative-performance, and “first” 100-hour protection claims. The outcome may modestly strengthen competitive advertising standards, but it does not represent a material financial catalyst for PG. National Advertising Division decision involving Carpe

Insiders Place Their Bets

In other Procter & Gamble news, insider Balaji Purushothaman sold 4,181 shares of the stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $160.71, for a total transaction of $671,928.51. Following the sale, the insider owned 11,296 shares of the company’s stock, valued at $1,815,380.16. This represents a 27.01% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Andre Schulten sold 3,914 shares of the firm’s stock in a transaction dated Monday, October 5th. The shares were sold at an average price of $145.34, for a total transaction of $568,860.76. Following the completion of the sale, the chief financial officer owned 65,618 shares of the company’s stock, valued at $9,536,920.12. The trade was a 5.63% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 58,647 shares of company stock valued at $9,268,508 over the last three months. Company insiders own 0.23% of the company’s stock.

Procter & Gamble Profile

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.